Teva Pharmaceutical Industries (TEVA) Operating Margin Growth (1y) (2017 - 2026)

Teva Pharmaceutical Industries (TEVA) Operating Margin Growth (1y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 304.00
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -157.00
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -650.00
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -2,102.00
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1,962.00
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 152.00
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -12,673.00
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -583.00
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -2,276.00
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 118,171.00

Historic Data

Download Data
DateValue
Mar 31, 2026 304.00
Dec 31, 2025 737.00
Sep 30, 2025 2,086.00
Jun 30, 2025 1,102.00
Mar 31, 2025 1,905.00
Dec 31, 2024 -1,796.00
Sep 30, 2024 -1,011.00
Jun 30, 2024 1,674.00
Mar 31, 2024 -535.00
Dec 31, 2023 4,116.00
Sep 30, 2023 -286.00
Jun 30, 2023 868.00
Mar 31, 2023 1,912.00
Dec 31, 2022 -2,610.00
Sep 30, 2022 -423.00
Jun 30, 2022 -4,043.00
Mar 31, 2022 -3,037.00
Dec 31, 2021 -721.00
Sep 30, 2021 12,518.00
Jun 30, 2021 1,041.00